202 related articles for article (PubMed ID: 8592617)
1. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
Marangella M; Vitale C; Petrarulo M; Linari F
Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
[TBL] [Abstract][Full Text] [Related]
2. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
[TBL] [Abstract][Full Text] [Related]
3. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
[TBL] [Abstract][Full Text] [Related]
4. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria.
Hoppe B; Kemper MJ; Bökenkamp A; Langman CB
Kidney Int; 1998 Sep; 54(3):921-5. PubMed ID: 9734617
[TBL] [Abstract][Full Text] [Related]
5. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
Ogawa Y; Machida N; Ogawa T; Oda M; Hokama S; Chinen Y; Uchida A; Morozumi M; Sugaya K; Motoyoshi Y; Hattori M
Urol Res; 2006 Feb; 34(1):12-6. PubMed ID: 16432691
[TBL] [Abstract][Full Text] [Related]
6. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
[TBL] [Abstract][Full Text] [Related]
7. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
[TBL] [Abstract][Full Text] [Related]
8. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases.
Marangella M; Petrarulo M; Vitale C; Daniele PG; Sammartano S; Cosseddu D; Linari F
Clin Sci (Lond); 1991 Oct; 81(4):483-90. PubMed ID: 1657494
[TBL] [Abstract][Full Text] [Related]
9. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.
Sikora P; Beck B; Zajaczkowska M; Hoppe B
Urol Res; 2009 Apr; 37(2):101-5. PubMed ID: 19183975
[TBL] [Abstract][Full Text] [Related]
10. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
[TBL] [Abstract][Full Text] [Related]
11. Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.
Hueppelshaeuser R; von Unruh GE; Habbig S; Beck BB; Buderus S; Hesse A; Hoppe B
Pediatr Nephrol; 2012 Jul; 27(7):1103-9. PubMed ID: 22366809
[TBL] [Abstract][Full Text] [Related]
12. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.
Geraghty R; Wood K; Sayer JA
Urolithiasis; 2020 Oct; 48(5):377-384. PubMed ID: 32719990
[TBL] [Abstract][Full Text] [Related]
13. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
D'Costa MR; Winkler NS; Milliner DS; Norby SM; Hickson LJ; Lieske JC
Am J Kidney Dis; 2019 Sep; 74(3):417-420. PubMed ID: 30910370
[TBL] [Abstract][Full Text] [Related]
14. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD.
Bunchman TE; Swartz RD
Perit Dial Int; 1994; 14(1):81-4. PubMed ID: 8312423
[No Abstract] [Full Text] [Related]
15. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy.
Dong F; Jiang S; Tang C; Wang X; Ren X; Wei Q; Tian J; Hu W; Guo J; Fu X; Liu L; Patzak A; Persson PB; Gao F; Lai EY; Zhao L
Free Radic Biol Med; 2022 Feb; 179():288-300. PubMed ID: 34767921
[TBL] [Abstract][Full Text] [Related]
16. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
[TBL] [Abstract][Full Text] [Related]
17. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
[TBL] [Abstract][Full Text] [Related]
18. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report.
Villani V; Gupta N; Elias N; Vagefi PA; Markmann JF; Paul E; Traum AZ; Yeh H
Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28261895
[TBL] [Abstract][Full Text] [Related]
19. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
[TBL] [Abstract][Full Text] [Related]
20. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.
Tomson CR; Channon SM; Parkinson IS; Morley AR; Lennard TW; Parrott NR; Laker MF
J Clin Pathol; 1988 Oct; 41(10):1107-13. PubMed ID: 3192733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
